Kodiak Sciences Inc

Kodiak Sciences Inc

96.80
USD
-3.93
(-3.90%)
-4.08EPS
6.10BMarket Cap
Apr 01Next Earn

Total Valuation

USD

As of September 30, 2026, Kodiak Sciences Inc carries a market capitalization of 6.10B, placing it among publicly traded companies globally. Its enterprise value stands at 6.05B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap6.10B
Enterprise Value6.05B

Important Dates

Kodiak Sciences Inc's next confirmed earnings release is scheduled for April 1, 2027.

Earnings Date4/1/2027

Share Statistics

As of September 30, 2026, Kodiak Sciences Inc has 64.31M shares outstanding.

Shares Outstanding64.31M

Valuation Ratios

These figures are as of September 30, 2026.

PB Ratio484.91
P/TBV Ratio484.91
P/FCF Ratio-33.17
P/OCF Ratio-33.82

Financial Position

As of September 30, 2026, Kodiak Sciences Inc maintains a current ratio of 1.70, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.

Current Ratio1.70
Quick Ratio1.62
Debt / Equity370.38
Debt / EBITDA-0.20

Financial Efficiency

Over the twelve months ended September 30, 2026, Kodiak Sciences Inc posted a negative return on equity (ROE) of -1,360.91, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -115.45, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 124.00, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)-1,360.91
Return on Assets (ROA)-115.45
Employee Count124.00

Stock Price Statistics

USD

As of the close on November 17, 2026, Kodiak Sciences Inc's stock has gained approximately 388.15% over the past 52 weeks. The 50-day moving average sits at 79.26, while the 200-day moving average is 46.68.

52-Week Price Change388.15%
50-Day Moving Average79.26
200-Day Moving Average46.68

Income Statement

USD

Over the twelve months ended September 30, 2026, Kodiak Sciences Inc generated - - in revenue and converted that into -246.76M in net income, yielding earnings per share of -4.08. EBITDA reached -227.26M, while operating income came in at -251.17M.

Operating Income-251.17M
Pretax Income-246.76M
Net Income-246.76M
EBITDA-227.26M
EBIT-251.17M
Earnings Per Share (EPS)-4.08

Balance Sheet

USD

As of September 30, 2026, Kodiak Sciences Inc holds 88.68M in cash and equivalents against 46.56M in total debt, resulting in a net debt position of -88.68M. Total book value stands at 12.57M, with working capital of 38.15M providing operational flexibility.

Cash & Cash Equivalents88.68M
Total Debt46.56M
Net Debt-88.68M
Equity (Book Value)12.57M
Book Value Per Share0.20
Working Capital38.15M

Cash Flow

USD

Kodiak Sciences Inc produced -169.49M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -3.32M in capital expenditures, free cash flow totaled -172.81M - equivalent to -2.86 per share.

Operating Cash Flow-169.49M
Capital Expenditures-3.32M
Free Cash Flow-172.81M
FCF Per Share-2.86

Dividends & Yields

These figures cover the twelve months ended September 30, 2026. Free cash flow yield is negative at -3.01: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -3.07, meaning Kodiak Sciences Inc raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-3.07
FCF Yield-3.01

Stock Splits

Kodiak Sciences Inc's most recent stock split took place on February 23, 2022 with a 1:5 split ratio.

Last Split Date2/23/2022
Split Ratio1:5

Scores

As of September 30, 2026, Kodiak Sciences Inc has an Altman Z-Score of 3.15, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.15